Table 6.

Identification of Potential Barriers and Limitations of Telemedicine in the Oral Health Practice

Variable	B	SE	95% CI	β	T	p values
Intercept	4.05	0.17	3.70–4.39	0.00	23.63	0.001*
C1No	0.18	0.21	−0.24–0.60	0.10	0.84	0.401
C2Yes	−0.08	0.13	−0.34–0.18	−0.09	−0.60	0.552
C3Yes	−0.02	0.16	−0.34–0.30	−0.02	−0.11	0.913
C3No	0.16	0.13	−0.11–0.43	0.18	1.20	0.234
C4No	−0.25	0.13	−0.50–0.01	−0.28	−1.91	0.060
C6Yes	−0.19	0.15	−0.48–0.10	−0.22	−1.30	0.198
R3Yes	0.02	0.11	−0.21–0.25	0.02	0.15	0.881
R5Yes	−0.32	0.11	−0.55–0.10	−0.37	−2.87	0.006*
R5No	−0.19	0.19	−0.56–0.19	−0.13	−1.00	0.321
R6 satisfied	0.03	0.13	−0.22–0.28	0.03	0.22	0.829
R6 dissatisfied	0.03	0.25	−0.47–0.52	0.01	0.10	0.917

Notes: A linear regression analysis was conducted to assess how the factors C1, C2, C3, C4, C6, R3, R5, and R6 significantly predicted F (future implications of telemedicine). *p < 0.05 was considered as significant. C1= “Was clinic deferred due to the COVID-19 pandemic?”, C2= “Are the respondent were familiar with the use of telemedicine?”, C3= “Does practice setup support the use of telemedicine?”, C4 = “Have respondent ever utilized any form of telemedicine before the COVID-19 pandemic?”, C6 = “Have respondent been in communication with patients via telemedicine during the COVID-19 pandemic?”, R3 = “ Do the consent of patients was taken before telemedicine session?”, R5 = “Was it convenient to use telemedicine?”, R6 = “Overall, how satisfied were the patients with the telemedicine services?”.